-
Signature
-
/s/ Kathleen P. Bloch attorney-in-fact for Edward R. Jones
-
Issuer symbol
-
CTSO
-
Transactions as of
-
09 Dec 2021
-
Net transactions value
-
-$0.42
-
Form type
-
4
-
Filing time
-
13 Dec 2021, 18:59:47 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CTSO |
Common Stock |
Options Exercise |
$16,500 |
+4,000 |
+5.1% |
$4.12 |
82,800 |
09 Dec 2021 |
Direct |
|
| transaction |
CTSO |
Common Stock |
Tax liability |
$16,500 |
-3,161 |
-3.8% |
$5.22 |
79,639 |
09 Dec 2021 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CTSO |
Stock Option (right to buy) |
Options Exercise |
$0 |
-4,000 |
-100% |
$0.000000* |
0 |
09 Dec 2021 |
Common Stock |
4,000 |
$4.12 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
1. Includes: (i) the following Restricted Stock Units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 10,339 shares of the Issuer's common stock owned by the reporting person, inclusive of the shares acquired after giving effect to the transactions reported on this Form 4.